Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:        
Net loss $ (9,484) $ (7,044) $ (38,570) $ (38,253)
Adjustments to reconcile net loss to cash used in operating activities:        
Depreciation and amortization     2,364 2,443
Stock-based compensation expense 632 2,537 2,218 6,915
Non-cash gain on settlement with licensor (6,743) (6,743)
Non-cash PPP loan payable forgiveness income (1,758) (1,758)
Non-cash impairment of licensed technology 1,355
Non-cash impairment of right-of-use lease asset 1,561
Non-cash impairment of construction-in-progress     1,792
Accretion and interest on short-term investments     (206) 256
Amortization of right-of-use lease assets     1,204 825
Non-cash interest     558
Loss on disposal of property and equipment     121
Change in operating assets and liabilities:        
Accounts receivable     3,000
Other receivables     (1,047)
Prepaid expenses and other current assets     1,432 1,801
Other assets     148 (23)
Accounts payable, accrued expenses and lease liabilities     (5,125) (4,459)
Deferred revenue     (296)
Change in payable to licensor     3,588
Net cash used in operating activities     (29,491) (35,408)
Cash flows from investing activities:        
Capital expenditures     (105) (903)
Proceeds from disposal of property and equipment     1,590
Purchases of short-term investments     (43,866) (15,164)
Proceeds from maturities of short-term investments     43,707 74,130
Net cash provided by investing activities     1,326 58,063
Cash flows from financing activities:        
Proceeds from ATM sales of common stock, net of issuance costs     4,189 7,699
Proceeds from exercise of stock options     831
Proceeds from issuance of Series A and Series B Convertible Redeemable Preferred Stock, net of issuance costs     22,468
Redemption of Series A and Series B Convertible Redeemable Preferred Stock     (26,250)
Net cash provided by financing activities     407 8,530
Net increase(decrease) in cash, cash equivalents and restricted cash     (27,758) 31,185
Cash, cash equivalents and restricted cash at beginning of period     38,829 13,571
Cash, cash equivalents and restricted cash at end of period 11,071 44,756 11,071 44,756
Supplemental cash flow information:        
Cash and cash equivalents 5,733 43,781 5,733 43,781
Restricted cash 5,338 975 5,338 975
Total cash, cash equivalents and restricted cash $ 11,071 $ 44,756 $ 11,071 $ 44,756